The hematopoietic stem cell MYB enhancer is essential for and recurrently amplified during T cell leukemogenesis
Carea Mullin(University of Michigan), Mark Y. Chiang(Children's Health Queensland Hospital and Health Service), Elizabeth Choe(University of Michigan), David T. Teachey(Children's Hospital of Philadelphia), Petri Pölönen(St. Jude Children's Research Hospital), Paul M. Evans(University of Michigan), Kelly R. Barnett(St. Jude Children's Research Hospital), Annie Wang(Yale University), Cher Sha(Baylor College of Medicine), Ashley F. Melnick(Michigan State University), Charles G. Mullighan(St. Jude Children's Research Hospital), Anna C. McCarter(Stanford Medicine), Marcin Cieślik(University of Michigan), Rami Khoriaty(University of Michigan), Alexander C. Monovich(University of Michigan), Yamei Deng(University of Michigan), Linda C. Samuelson(University of Michigan), Rohan Kodgule(Washington University in St. Louis), Karena Lin(University of Michigan), Koral Campbell, Russell J.H. Ryan(University of Michigan), Alexey I. Nesvizhskii(University of Michigan), Sarah Khan(University of Michigan), Daniel Savic(St. Jude Children's Research Hospital), Theresa M. Keeley(University of Michigan), Qing Li(Army Medical University), Qing Wang(Jiangnan University), Morgan Jones(Cardiff University), Shannon Liang(University of Michigan), Zeel Shukla(University of Michigan), Ashwin Iyer(University of Michigan), Jannaldo Nieves-Salva(University of Michigan), Felipe da Veiga Leprevost(University of Michigan)
Cited by 0
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
|The Lancet Oncology|2009|1k